Myosin MYH11 were previously found to be associated with variety of cancers, such as oral squamous cell carcinoma, meanwhile, a recent study has described MYH11 as a potential biomarker and candidate drug target for head and neck cancer management (Islam et al., 2018). This evidence concerns the gene MYH11 and cancer.